ROHTO Eye Drops Recall: 12 Million Bottles Pulled for Sterility Concerns (FDA Class II Recall) [QKVMYtcsFYD]

The FDA has announced a nationwide Class II recall affecting nearly 12 million bottles of Rohto Cooling Eye Drops due to a lack of assurance of sterility. This means the manufacturer cannot guarantee the drops are free from potentially harmful microorganisms. Affected products include eight Rohto Cooling Eye Drops varieties, sold in single and twin packs, marketed for redness relief, dryness, eye strain, and cooling effects. Expiration dates range from July 2025 through February 2029. 🚨 Products Included Rohto ALL-IN-ONE Rohto Max Strength Rohto Optic Glow Rohto Digi Eye Rohto Dry Aid Rohto Cool Relief (Plus, twin‑pack versions) ⚠️ What Consumers Should Do Stop using immediately if your lot number matches the recall. Dispose or return for a full refund. Compare your packaging’s lot number + expiration date with the FDA recall notice. 🧪 Why the Recall Matters Because eye drops come into direct contact with the eye, sterility is critical. While the FDA classifies this as a Class II recall—meaning temporary or reversible health effects are possible—serious consequences are unlikely. #RohtoRecall #EyeDropRecall #FDANews #ConsumerSafety #CPLSafety #HomeSafety #ProductRecall #SterilityConcern #DailySafetyUpdate

• 3HeEgpVzxKa
• audFsrjWMfU
• rPI3EnCHEhK
• Foov8JJf6NB